Clinical Study Of Raal churna (resin of shorea robusta) And Nagkeshara(Mesua ferrea Linn.) Churna In the treatment Of White vaginal Discharge(Leucorrhoea) in females.

Pharmaco-Therapeutic Study Of Shala(Shorea robusta Gaertn.f)Niryasa And Nagkeshara(Mesua ferrea Linn.) Churna In Management Of Sweta Pradara - A Comparative Study.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/12/047900

Enrollment

Registered

2022-12-06

Start date

Unknown

Completion date

Unknown

Last updated

2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N70-N77- Inflammatory diseases of female pelvic organs

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Married Female Patients Of Age 18 to 55 Years 2 Patients Presenting With Complaints Of White Discharge Per Vginum 3 Patients Willing To Register And Sign The Consent Form

Exclusion criteria

Exclusion criteria: 1 Unmarried female 2 Patient having any type of malignancy 3 Patient having positive VDRL HIV HbsAg Tuberculosis Pelvic inflammatory diseases and STDs 4 Pregnant women and Lactating Mothers 5 Patient having any Chronic systemic Illness 6 Age below 18 year and above 55 year

Design outcomes

Primary

Measure	Time frame
Change in the Signs and Symptoms of white discharge including Amount of discharge at the time of baseline and at the end of the treatment (After 6 weeks)Timepoint: Change in the Signs and Symptoms of white discharge including Amount of discharge at the time of baseline and at the end of the treatment (After 6 weeks)	—

Secondary

Measure	Time frame
Assessment of change in the clinical parameters on 15th dayTimepoint: 30th and 45th day	—

Countries

India

Contacts

Public ContactDr Shiromani Mishra

Government Dhanvantari Ayurvedic Medical College And Hospital Ujjain

shiromishra@gmail.com9893158853

Outcome results